Study Stopped
Stopped due to lack of enrollement
The Impact of the Timing of Trigger on IVF Success
1 other identifier
interventional
29
1 country
1
Brief Summary
The aim of this study is to examine the length of ovarian stimulation with the timing of trigger in an IVF cycle and its potential to impact patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 6, 2016
CompletedFirst Posted
Study publicly available on registry
December 13, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 15, 2022
CompletedOctober 14, 2022
October 1, 2022
5.5 years
December 6, 2016
October 12, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Euploid Embryos: the percentage of euploid embryos produced as analyzed by comprehensive chromosomal screening, of total embryos tested
4 weeks after egg retrieval
Secondary Outcomes (2)
Egg maturation: the proportion of mature eggs of total number of eggs retrieved
1 week after egg retrieval
Live birth outcomes: the incidence of pregnancy resulting in live birth following embryo transfer of embryos produced by this IVF cycle
9 months after frozen embryo transfer
Study Arms (2)
Testing group
EXPERIMENTALTiming of trigger at end of ovarian stimulation in an IVF cycle: trigger when 2 follicles reach 18mm, OR 1 follicle reaches 18mm AND 1 follicle is between 16-18mm.
Control group
NO INTERVENTIONInterventions
Eligibility Criteria
You may qualify if:
- Planning to move forward with an IVF cycle
- Have met the requirements of being a patient at CCRM Colorado
- AMA: 39-44 years old And/or
- DOR: AMH \< 1 \& FSH \>10 (age independent)
You may not qualify if:
- Contraindication for pregnancy
- Have not fulfilled requirements for IVF cycle
- Single gene couple or chromosomal rearrangement
- Severe male factor or testicular surgical sperm removal (need sufficient sperm for ICSI)
- One ovary
- Uterine anomalies
- Stage III or IV endometriosis
- Explained recurrent miscarriage
- PCO or PCOS
- Using donor oocyte or gestational carrier
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Colorado Center for Reproductive Medicine
Lone Tree, Colorado, 80124, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mandy Katz-Jaffe, PhD
CCRM, FLC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 6, 2016
First Posted
December 13, 2016
Study Start
November 1, 2016
Primary Completion
May 9, 2022
Study Completion
June 15, 2022
Last Updated
October 14, 2022
Record last verified: 2022-10